Jacob Møller, MD, the principal investigator, discusses the New England Journal of Medicine trial with Dr. Chuck Simonton. They begin by talking about the unique phenotype of the patients enrolled in the trial and the role of left ventricular unloading in patients supported with Impella®. Dr. Møller then discusses new data he presented at TCT 2024. This includes data demonstrating faster lactate clearance in patients supported with Impella, how acute kidney injury (AKI) is often related to suction events with Impella, new bleeding data insights and factors contributing to why women didn’t appear to benefit in the trial.